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Abstract 
This first clinical prospective study was conducted to use of technetium-99m immu-
noglobulin G (99mTc-IgG) as compared with autologous 99mTc-red blood cells (RBC) in gat-
ed blood pool ventriculography. We studied 12 patients who referred to us for a possible 
diagnosis of liver hemangioma or infection. Six patients underwent gated planar blood 
pool (GPBP) acquisition using 99mTc-RBC and 6 GPBP acquisition using 99mTc-IgG. The use 
of 99mTc-IgG in cardiac blood pool studies provided comparable images to 99mTc-RBC. In 
conclusion, 99mTc-IgG, which is readily available and needs only a single injection, may 
be an attractive alternative to 99mTc-RBC for the estimation of various cardiac function 
parameters like left ventricular function . 
Introduction
L eft ventricular (LV) function and ejection fraction (EF) studied by radionuclidicor echocardiographic techniques have long been diagnostic factors associated with cardiac function [1-3]. However, echocardiographic investigations (ECHOC) may 
have poor reproducibility and be unable to diagnose some lesions like those in the endo-
cardium and the apex [4, 5] and gated single photon emission tomography (GSPET) per-
fusion studies may be difficult to identify lesions with marked hypoperfusion [6].
Gated blood pool ventriculography (GBPV) is usually carried out by labeling autologous 
red blood cells (RBC) with 99mTc-RBC [7]. Practical drawbacks of the 99mTc-RBC technique 
time and labor and the necessary manipulations of blood samples with a possible risk of 
contamination [8]. A number of studies have tried to use other blood-pool agents in addi-
tion to 99mTc-RBC [9-13]. 
This article presents the first clinical prospective study using 99mTc-gamma immunoglobu-
lin (IgG) as compared with 99mTc-RBC in GBPV, by measuring organ activity ratios and image 
quality. 
Patients and methods 
The study population included 12 patients (7 men and 5 women mean age 59.92±8.07 
years) who had been referred to us for possible diagnosis of liver hemangioma or infection 
(Table 1). None had symptoms of typical or atypical ischemic heart disease (IHD) such as 
chest pain, history of myocardial infarction (MI), congestive heart failure, arythmia or his-
tory of coronary interventions such as catheterization or coronary angioplasty. 
Six patients underwent GBPV acquisition using 99mTc-RBC (Fig. 1), and the remaining six 
cases underwent GBPV with 99mTc-IgG (Fig. 2). 
This study complied with the declaration of Helsinki and was approved by the Institu-
tional Ethics Committee of Golestan University of Medical Science. All patients signed a 
written fully informed consent.
Technetium-99m-RBC labeling was carried out using a modified in vitro method (ex-vivo) 
[10, 14]. The radiopharmaceutical was administered by direct intravenous (i.v.) injection [15]. 
According to this technique, at least 10min after stannous chloride administration (0.5mg 
to 2mg), 2-3mL of blood is withdrawn from the subject into a containing 99mTcO-4 syringe, 
and then administered using separate venous access to that used for the stannous chlo-
ride administration previously. More than 95% labeling efficiency was achieved by this 
direct technique. For 99mTc-IgG preparation, a human nonspecific polyclonal IgG solution 
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with a concentration of about 10mg/mL in 0.01 M phosphate 
buffered saline (PBS) of pH 7.4 was acquired. Protein con-
centration was appraised by Lowry technique [16]. The IgG 
was reduced by reacting with a molar excess of 2-mecap-
toethanol 2000:1 (2-ME:IgG) and was incubated for 30min at 
room temperature. The reduced solution was then purified 
by eluting through a 1×15cm sephadex G25 column, using 
nitrogen purged phosphate buffered saline (PBS) as mobile 
phase. Aliquots containing 1mg of reduced protein and 20μL 
of previously reconstituted solution with 5mL of saline were 
mixed, passed through a 0.22μ membrane filter and then fro-
zen in -80°C. The frozen products were lyophilized for 48h, 
sealed under vaccum, and stored at 4°C until use. For 99mTc 
labeling, vials of lyophilized reduced IgG were reconstituted 
with 740MBq of 99mTcO-4 eluted from a 
99Mo/99mTc generator 
(Atomic Energy Organization of Iran, Tehran, Iran) [16]. The 
total cost of each compound was approximately $60.
Gated BPV images were obtained and processed with 
commercially available software. For LVEF assessment, an 
observer (H.J) delineated the initial LV contours at end sys-
tole (ES) and end diastole (ED). 
Background (bg) region of interest (ROI) were also ac-
quired by use of a 2 to 3 pixel-wide crescent-shaped region 
located about 2 pixels far from the posterolateral wall. After 
the subtraction of a bg region surrounding the LV, EF was 
calculated by following formula:
EF(%) = [(ED counts - ES counts)/ED counts] * 100.
In addition, activities within the aforementioned bg region 
and the ED image of the LV were calculated and expressed in 
counts per pixel (c/p) to determine the LV/bg ratio.
In order to evaluate the activity ratios in different organs, 
regions of interest (ROI) were manually drawn over the LV, 
right ventricle (RV), right lung, left lung, aorta, liver, and 
spleen on the static anterior datasets at 20min (early) and at 
180min (delayed) post injection of 99mTc-RBC (Fig. 1) and of 
99mTc-IgG (Fig. 2). These ROI also were expressed in c/p. The 
c/p ratios between early and delayed views were compared 
for each ROI. 
Image quality was also blindly assessed by two observers 
(M.M and M.A) using as criteria the simplicity of outlying the 
ED and ES, LV edges. Quality was classified as good, mild, 
or poor for both radiotracers. The data were expressed as 
mean±standard deviation (±SD); the Mann–Whitney U test 
was applied for quantitative comparison, and differences in 
proportion (categorical variables) were assessed by the chi-
square test. A P value of <0.05 was considered statistically 
significant. 
Results
None of the patients had any adverse reactions such as 
nausea, flushing, coughing, dyspnea, muscle cramps or diz-
ziness after the i.v. injection of 99mTc-IgG. The mean acquisi-
tion times following injection of each radiotracer are shown 
in Table 1. Observers 1 and 2 based upon image qualities 
considered both radiotracers as of good quality for all par-
ticipants. The demographic data and GBPV parameters in-
cluding mean count/frame, EF, peak filling rate–end diastolic 
volume per second(PFR-EDV/S), peak filling rate (PFR), peak 
emptying rate (PFR)– EDV/sec, PER and LV/BKG between the 
two groups were not statistically different (Table 1).
A contrast analysis of both compounds was carried out in 
terms of organ c/p ratios between early and delayed images. 
The mean c/p of the LV and the RV to the bg ratios on early 
and delayed views in patients with 99mTc-IgG were greater, 
relative to patients who had been tested with radiolabeled 
99mTc-RBC (Table 2). The ten (as shown in Table 2) ratios in the 
early and delayed views between the two radiotracers were 
not significantly different (P value>0.05).
In addition, organ ROI c/p was compared with respect to 
the biodistribution of the two radiopharmaceuticals over 
time by subtracting ROI c/p of early acquired, from delayed 
ROI of the static images. This comparison showed that the 
washout rate of 99mTc-IgG relative to 99mTc-RBC was not sig-
nificantly different (Fig. 3). 
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Table 1. The main characteristics and results of the two groups studied
Radiopharmaceutical 99mTc-RBC 99mTc-IgG P value
Age (year) 62.00± 8.87 57.83±7.36 0.37
Male/Female 4/2 3/3 0.55
Post injection time of 
acquisition (min.) 75.83±11.75 80.00±7.09 0.63
Mean count/frame 326.50±187.30 424.17±239.81 0.42
EF (%) 59.00±7.64 58.33±16.03 0.52
PFR-EDV/S 3.20 ±0.77 2.49±0.62 0.15
PFR (ms) 459.50 ±39.09 491.33±49.84 0.15
PER-EDV/S -3.02±0.51 -2.62±0.74 0.15
PER(ms) 97.00±20.74 112.00±21.53 0.15
LV/BKG 2.55±0.99 2.11±0.78 0.52
EF, ejection fraction; PFR-EDV/S, peak filling rate–end diastolic volume per second; PFR (ms), peak filling rate in millisecond; PER-EDV/S, peak 
emptying rate–end diastolic volume second; PER(ms), peak emptying rate in millisecond; LV/BKG, left ventricle/ bg.
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Figure 3. Comparison of the biodistribution of both radiopharmaceuticals by 
using c/p of ROI in different organs between early and delayed images. For this 
purpose, activities of early acquired ROI were subtracted from delayed ROI views 
of the static images.
Discussion
Despite the advantages of planar GBPV, there are limita-
tions, such as operator-dependent variability in determin-
ing the best septal view and underestimation of the LVEF in 
anterior and inferior myocardial infarction, which are over-
come by the SPET mode [17, 18].
The LV and RV activity divided to bg did not differ between 
the two agents, so the blood pool images with 99mTc-IgG may 
be adequate for clinical application. 
Other 99mTc-labeled agents, such as human serum albu-
min (99mTc-HSA) [10], diethylen triamine penta acetic-human 
serum albumin (DTPA-HSA) [11], and bis diethylphosphi-
noethane bis-t butylisocyanide (99mTc-DEPIC) [13] have been 
used in GBPV acquisition [10, 11, 13]. As for these techniques, 
because of the rather weak binding of the radionuclide to 
the protein and the resulting fast extravascular diffusion 
[11], labeled RBC remain the radiopharmaceutical in routine 
practice [19]. 
Our work showed that 99mTc-IgG had a better washout rate 
from blood pools and background regions than 99mTc-RBC 
when used for cardiac blood-pool imaging [18]. Such an in-
creased washout rate does not reduce effective tracer activ-
ity and the target-to background ratios. Although we did not 
document the washout rate directly by obtaining sequential 
blood samples, the heart-to-background ratios of the two 
radiopharmaceuticals was an indicator for this finding.
Our findings may indicate that 99mTc-IgG is a promising 
agent for GBPV having a stable biodistribution and provid-
ing good image quality up to 3h post injection. Even on the 
delayed study, a good contrast between the LV and the sur-
rounding organs was acquired, permitting a precise calcula-
tion of the EF value. We were unable to find a similar study in 
the literature. Further studies with more cases are needed to 
confirm these findings.
In conclusion, our results showed that the use of 99mTc-IgG 
in cardiac blood pool studies might be an alternative to 
99mTc-RBC for the measurement of LV and EF function. 
 All authors declare that they have no conflicts of interest
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Table 1. The main characteristics and results of the two groups studied
Parameter Phase 99mTc-RBC 99mTc-IgG P value
LV/Liver
early 1.71±0.48 2.02±0.29 0.26
delayed 1.78±0.48 1.93±0.30 1.00
LV/Spleen
early 1.79±1.18 2.07±0.85 0.33
delayed 1.55±0.57 1.78±0.45 0.52
LV/Lung
early 1.43±0.48 1.70±0.18 0.33
delayed 1.34±0.48 2.00±1.11 0.20
RV/Liver
early 2.43±0.50 2.63±0.58 0.74
delayed 2.04±0.67 2.50±0.63 0.42
RV/Spleen
early 2.40±1.31 2.69±1.15 0.52
delayed 1.73±0.61 2.32±0.68 0.20
RV/Lung
early 2.00±0.43 2.20±0.41 0.42
delayed 1.68±0.80 2.51±1.24 0.26  
Aorta/Liver
early 0.83±0.28 0.81±0.32 0.87
delayed 0.88±0.30 0.83±0.31 0.87
Aorta/Spleen
early 0.83±0.49 0.79±0.40 0.52
delayed 0.82±0.42 0.73±0.19 0.87
Aorta/Lung
early 0.67±0.16 0.67±0.22 0.87
delayed 0.69±0.33 0.80±0.35 0.52
Liver/Spleen
early 1.05±0.66 1.05±0.46 0.63
delayed 0.93±0.40 0.95±0.32 0.87
ROI, region of interest; LV, left ventricle; RV, right ventricle.
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